Immunobiotics: Interactions of Beneficial Microbes with the Immune System
The term “immunobiotics” has been proposed to define microbial strains able to beneficially regulate the mucosal immune system. Research in immunobiotics has significantly evolved as researchers employed cutting-edge technologies to investigate the complex interactions of these beneficial microorgan...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2018 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (309 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544251104498 |
---|---|
ctrlnum |
(CKB)4920000000094201 (oapen)https://directory.doabooks.org/handle/20.500.12854/49984 (EXLCZ)994920000000094201 |
collection |
bib_alma |
record_format |
marc |
spelling |
Haruki Kitazawa auth Immunobiotics: Interactions of Beneficial Microbes with the Immune System Immunobiotics Frontiers Media SA 2018 1 electronic resource (309 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics The term “immunobiotics” has been proposed to define microbial strains able to beneficially regulate the mucosal immune system. Research in immunobiotics has significantly evolved as researchers employed cutting-edge technologies to investigate the complex interactions of these beneficial microorganisms with the immune system. During the last decade, our understanding of immunobiotics-host interaction was profoundly transformed by the discovery of microbial molecules and host receptors involved in the modulation of gut associated immune system, as well as the systemic and distant mucosal immune systems. In recent years, there has been a substantial increase in the number of reports describing the beneficial effects of immunobiotics in diseases such as intestinal and respiratory infections, allergy, inflammatory bowel disease, obesity, immunosuppression, and several other immune-mediated conditions. Evidence is also emerging of immunobiotics related molecules with immunomodulatory functions leading to the production of pharmabiotics, which may positively influence human or animal health. Therefore, research in immunobiotics continue to contribute not only to food but also medical and pharmaceutical fields. The compilation of research articles included in this ebook should help reader to have an overview of the recent advances in immunobiotics. English infection inflammation mucosal immune system beneficial microbes lactic acid bacteria probiotics 2-88945-382-0 Julio Villena auth |
language |
English |
format |
eBook |
author |
Haruki Kitazawa |
spellingShingle |
Haruki Kitazawa Immunobiotics: Interactions of Beneficial Microbes with the Immune System Frontiers Research Topics |
author_facet |
Haruki Kitazawa Julio Villena |
author_variant |
h k hk |
author2 |
Julio Villena |
author2_variant |
j v jv |
author_sort |
Haruki Kitazawa |
title |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
title_full |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
title_fullStr |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
title_full_unstemmed |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
title_auth |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
title_alt |
Immunobiotics |
title_new |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
title_sort |
immunobiotics: interactions of beneficial microbes with the immune system |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2018 |
physical |
1 electronic resource (309 p.) |
isbn |
2-88945-382-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT harukikitazawa immunobioticsinteractionsofbeneficialmicrobeswiththeimmunesystem AT juliovillena immunobioticsinteractionsofbeneficialmicrobeswiththeimmunesystem AT harukikitazawa immunobiotics AT juliovillena immunobiotics |
status_str |
n |
ids_txt_mv |
(CKB)4920000000094201 (oapen)https://directory.doabooks.org/handle/20.500.12854/49984 (EXLCZ)994920000000094201 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Immunobiotics: Interactions of Beneficial Microbes with the Immune System |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652263891009536 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02476nam-a2200373z--4500</leader><controlfield tag="001">993544251104498</controlfield><controlfield tag="005">20231214133412.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2018 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094201</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/49984</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094201</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Haruki Kitazawa</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunobiotics: Interactions of Beneficial Microbes with the Immune System</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Immunobiotics</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (309 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The term “immunobiotics” has been proposed to define microbial strains able to beneficially regulate the mucosal immune system. Research in immunobiotics has significantly evolved as researchers employed cutting-edge technologies to investigate the complex interactions of these beneficial microorganisms with the immune system. During the last decade, our understanding of immunobiotics-host interaction was profoundly transformed by the discovery of microbial molecules and host receptors involved in the modulation of gut associated immune system, as well as the systemic and distant mucosal immune systems. In recent years, there has been a substantial increase in the number of reports describing the beneficial effects of immunobiotics in diseases such as intestinal and respiratory infections, allergy, inflammatory bowel disease, obesity, immunosuppression, and several other immune-mediated conditions. Evidence is also emerging of immunobiotics related molecules with immunomodulatory functions leading to the production of pharmabiotics, which may positively influence human or animal health. Therefore, research in immunobiotics continue to contribute not only to food but also medical and pharmaceutical fields. The compilation of research articles included in this ebook should help reader to have an overview of the recent advances in immunobiotics.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucosal immune system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">beneficial microbes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunobiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lactic acid bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-382-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Julio Villena</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:53:04 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337587890004498&Force_direct=true</subfield><subfield code="Z">5337587890004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337587890004498</subfield></datafield></record></collection> |